Lensar, Inc.

Lensar, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

LENSAR® is the leader in Robotic Cataract Laser Technology for refractive cataract surgery. Our mission is to take the time to understand the needs of surgeons and their patients so that we can innovate our technology to ensure we meet their dynamic needs. LENSAR, Inc. is committed to revolutionizing refractive eye surgery. Our success depends on talented and motivated individuals who share our passion for making a difference in patients’ lives. We are a young and vibrant company located in Orlando, FL. We pride ourselves on having a highly collaborative, innovative environment where initiatives and teamwork are valued and individual efforts are recognized. If you’re looking for a career that enables you to pursue both professional and personal goals, we invite you to consider a career at LENSAR, Inc. Click on our website link below for current employment opportunities. Interested in learning more? Contact us at marketing@lensar.com
Looking for a particular Lensar, Inc. employee's phone or email?

Lensar, Inc. Questions

News

LENSAR Reports Second Quarter 2025 Results and Provides Business Update - Yahoo Finance

LENSAR Reports Second Quarter 2025 Results and Provides Business Update Yahoo Finance

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

LENSAR, Inc. Grants 660 Restricted Stock Units to New Non-Executive Employees as Inducement for Employment - Quiver Quantitative

LENSAR, Inc. Grants 660 Restricted Stock Units to New Non-Executive Employees as Inducement for Employment Quiver Quantitative

Major Medical Tech Deal: Alcon Buys LENSAR at 47% Premium, Eyes $32B Cataract Market - Stock Titan

Major Medical Tech Deal: Alcon Buys LENSAR at 47% Premium, Eyes $32B Cataract Market Stock Titan

LENSAR Reports First Quarter 2025 Results and Provides Business Update - Yahoo Finance

LENSAR Reports First Quarter 2025 Results and Provides Business Update Yahoo Finance

Alcon Agrees to Acquire LENSAR, Inc. - GlobeNewswire

Alcon Agrees to Acquire LENSAR, Inc. GlobeNewswire

Medical Laser Company LENSAR Issues 660 Restricted Stock Units to Three New Non-Executive Hires - Stock Titan

Medical Laser Company LENSAR Issues 660 Restricted Stock Units to Three New Non-Executive Hires Stock Titan

LENSAR, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Quiver Quantitative

LENSAR, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 Quiver Quantitative

Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon - Latham & Watkins LLP

Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon Latham & Watkins LLP

Alcon lines up Lensar deal to expand laser cataract surgery options - Optics.org

Alcon lines up Lensar deal to expand laser cataract surgery options Optics.org

LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System - Business Wire

LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System Business Wire

Alcon agrees to purchase LENSAR - Ophthalmology Times

Alcon agrees to purchase LENSAR Ophthalmology Times

LENSAR Expands Team with 660 RSU Inducement Grants for Strategic New Hires - Stock Titan

LENSAR Expands Team with 660 RSU Inducement Grants for Strategic New Hires Stock Titan

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - GlobeNewswire

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update GlobeNewswire

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

ALC Stock Rises Following the Merger Agreement With LENSAR - Yahoo Finance

ALC Stock Rises Following the Merger Agreement With LENSAR Yahoo Finance

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 - Stock Titan

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 Stock Titan

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Stock Titan

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock Titan

Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million - VisionMonday

Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million VisionMonday

Alcon signs merger agreement to acquire Lensar - Medical Device Network

Alcon signs merger agreement to acquire Lensar Medical Device Network

Alcon to Acquire Lensar for up to $430 million. - Medical Device and Diagnostic industry

Alcon to Acquire Lensar for up to $430 million. Medical Device and Diagnostic industry

Alcon to buy Lensar in deal worth up to $430M - The Business Journals

Alcon to buy Lensar in deal worth up to $430M The Business Journals

Alcon agrees to acquire Lensar and its robotic cataract laser system - MassDevice

Alcon agrees to acquire Lensar and its robotic cataract laser system MassDevice

LENSAR And Alcon: Assessing Potential Outcomes (NASDAQ:LNSR) - Seeking Alpha

LENSAR And Alcon: Assessing Potential Outcomes (NASDAQ:LNSR) Seeking Alpha

VIDEO: Lensar, Oertli working to integrate phaco technology in Ally system - Healio

VIDEO: Lensar, Oertli working to integrate phaco technology in Ally system Healio

Swiss meditech Alcon inks eyecare deal with US's Lensar - Medical Xpress

Swiss meditech Alcon inks eyecare deal with US's Lensar Medical Xpress

Lensar integrating phacoemulsification technology into adaptive cataract treatment system - Ophthalmology Times

Lensar integrating phacoemulsification technology into adaptive cataract treatment system Ophthalmology Times

LENSAR: It Is All About The Contingent Value Right Now (NASDAQ:LNSR) - Seeking Alpha

LENSAR: It Is All About The Contingent Value Right Now (NASDAQ:LNSR) Seeking Alpha

Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely - simplywall.st

Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely simplywall.st

LENSAR Reports Second Quarter 2025 Results and Provides Business Update - TradingView

LENSAR Reports Second Quarter 2025 Results and Provides Business Update TradingView

SEC Crypto Counsel Named to Head CFTC - PYMNTS.com

SEC Crypto Counsel Named to Head CFTC PYMNTS.com

Robotic future may offer precision, efficiency for cataract surgery - Healio

Robotic future may offer precision, efficiency for cataract surgery Healio

FTC Probing Alcon's $430M Lensar Deal - Law360

FTC Probing Alcon's $430M Lensar Deal Law360

FTC Extends Waiting Period for LENSAR Merger - TipRanks

FTC Extends Waiting Period for LENSAR Merger TipRanks

VIDEO: Surgeon highlights features of Ally adaptive cataract treatment system - Healio

VIDEO: Surgeon highlights features of Ally adaptive cataract treatment system Healio

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript - Yahoo

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript Yahoo

Eye care product makers Alcon, LENSAR get second request from US FTC - MLex

Eye care product makers Alcon, LENSAR get second request from US FTC MLex

LENSAR Receives FDA Clearance of Five New Performance Application Upgrades to its LENSAR Laser System - cataractnewstoday.com

LENSAR Receives FDA Clearance of Five New Performance Application Upgrades to its LENSAR Laser System cataractnewstoday.com

LensAR cataract procedures carried out in US - Optics.org

LensAR cataract procedures carried out in US Optics.org

Cornea-Cutting Laser Cleared for Cataract Surgery | Business | Apr 2013 - Photonics Spectra

Cornea-Cutting Laser Cleared for Cataract Surgery | Business | Apr 2013 Photonics Spectra

LENSAR (NASDAQ:LNSR) versus Pressure BioSciences (OTCMKTS:PBIO) Head-To-Head Review - Defense World

LENSAR (NASDAQ:LNSR) versus Pressure BioSciences (OTCMKTS:PBIO) Head-To-Head Review Defense World

Top Lensar, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant